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Introduction
Clathrin heavy chain 17 (CHC17) is well characterized as a coat 
protein required for vesicle formation at the plasma membrane, 
the TGN, and endosomes (Brodsky et al., 2001). Most vertebrates 
have a second clathrin heavy chain isoform (CHC22), with each 
isoform named for the encoding human chromosome. We recently 
identified a role for CHC22 in trafficking the glucose transporter 4 
(GLUT4) in skeletal muscle and fat (Vassilopoulos et al., 2009), 
which is independent from that of CHC17. In apparent contrast, a 
recent study of transfected cells suggested functional redundancy 
of the CHCs (Hood and Royle, 2009). The study reported here 
localizes the distinct function of endogenous CHC22 relative to 
the known cellular functions of CHC17 and thereby defines the 
specialized contribution of CHC22 to membrane traffic pathways.
CHC17 and CHC22 have 85% sequence identity; however, 
key residue differences have been conserved during evolution. 
These are predominantly found in regions that bind clathrin 
adaptors and the regulatory clathrin light chains (CLCs) in 
CHC17 (Wakeham et al., 2005). CHC17 interactions with adap-
tor proteins are required for cargo capture and cellular localiza-
tion of CHC17 lattice formation on membranes and vesicles 
(Brodsky et al., 2001). These processes involve adaptor protein 
(AP) complex AP1 and Golgi-localized, gamma ear–containing, 
ARF-binding proteins (GGAs) 1–3 at the TGN, AP1, AP3, and 
probably GGAs at endosomes, and AP2 at the plasma membrane 
(Benmerah and Lamaze, 2007; Ungewickell and Hinrichsen, 
2007). CHC22 associates with AP1 and AP3 adaptors but not the 
endocytic AP2 complex (Liu et al., 2001; Vassilopoulos et al., 
2009). Consequently, skeletal muscle cells depleted of CHC22 
show normal endocytosis (Vassilopoulos et al., 2009). Both CHCs 
form trimers but do not cotrimerize or coassemble and CHC22 
does not bind CLCs, which influence CHC17 assembly and inter-
action with the actin cytoskeleton (Chen and Brodsky, 2005). 
In place of CLCs, CHC22 can bind sorting nexin 5 (SNX5), a 
participant in macropinocytosis and retromer-mediated retrograde 
transport (Towler et al., 2004; Kerr et al., 2006; Wassmer et al., 
Clathrin heavy chain 22 (CHC22) is an isoform of the well-characterized CHC17 clathrin heavy chain, a coat component of vesicles that mediate 
endocytosis and organelle biogenesis. CHC22 has a dis-
tinct role from CHC17 in trafficking glucose transporter 4 
(GLUT4) in skeletal muscle and fat, though its transfection 
into HEK293 cells suggests functional redundancy. Here, 
we show that CHC22 is eightfold less abundant than 
CHC17 in muscle, other cell types have variably lower 
amounts of CHC22, and endogenous CHC22 and CHC17 
function independently in nonmuscle and muscle cells. 
CHC22 was required for retrograde trafficking of certain 
cargo molecules from endosomes to the trans-Golgi net-
work (TGN), defining a novel endosomal-sorting step 
distinguishable from that mediated by CHC17 and ret-
romer. In muscle cells, depletion of syntaxin 10 as well as 
CHC22 affected GLUT4 targeting, establishing retro-
grade endosome–TGN transport as critical for GLUT4 
trafficking. Like CHC22, syntaxin 10 is not expressed in 
mice but is present in humans and other vertebrates, im-
plicating two species-restricted endosomal traffic proteins 
in GLUT4 transport.
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describing their functional differentiation or compensation (Hood 
and Royle, 2009; Vassilopoulos et al., 2009). Levels of CHC22 
relative to total protein varied between nine cell lines analyzed, 
derived from different tissues (Fig. 1 A). Myoblast cultures and 
HeLa cells had the highest expression. Cell lines derived from 
other human tissues all expressed some CHC22, but consider-
ably less, with the lowest expression in the liver cell line HepG2 
and the natural killer cell line NKL. This is consistent with pre-
dicted expression based on mRNA levels in different tissues 
(Kedra et al., 1996; Sirotkin et al., 1996). The murine skeletal 
muscle cell line C2C12 had no CHC22 protein, as expected from 
the murine CHC22 pseudogene. The levels of CHC17 were far 
less variable between cell lines, indicating that the ratios of 
CHC22 to CHC17 vary between tissues. To determine these ratios 
from absolute protein levels of each CHC, the antibodies used 
for immunoblotting were calibrated against known amounts of 
recombinant protein fragments of each CHC. Dilutions of cell 
lysates were correlated with these standards based on immuno-
blotting signals (Fig. 1 B). These experiments revealed that the 
ratios of CHC22 to CHC17 are 1:8 for LHCNM2 and 1:12 in 
HeLa. Thus, under endogenous conditions, there is 8- to 12-fold 
more CHC17 in cells than CHC22, even in cells that have the 
highest amount of CHC22.
To further study the functional relationship between CHCs 
at normal levels of expression, we used siRNA to individually 
down-regulate both CHCs in HeLa cells (Fig. 1 C). In non-
treated cells (not depicted) and cells treated with control siRNA, 
immunofluorescence detection of CHC22 revealed a punctate 
staining pattern with a more uniform intracellular distribution 
than CHC17, lacking the strong perinuclear crescent typical of 
CHC17 labeling in the TGN. Minor colocalization between 
CHC22 and CHC17 was confined to peripheral compartments 
(Fig. 1 D; Fig. S1 A). In cells depleted of CHC17, CHC22 staining 
appeared marginally brighter in the perinuclear region (Fig. 1 E; 
Fig. S1 B) and there was slightly more CHC22 colocalized with 
AP1 (Fig. S1 E) compared with control-treated cells (Fig. S1 D). 
This change in distribution may reflect increased membrane 
recruitment of CHC22 in the absence of CHC17, accounting 
for the modest increase in CHC22 protein levels detected by 
immunoblotting after CHC17 depletion (Fig. 1 C). In contrast, 
CHC17 distribution and levels (Fig. 1 F; Fig. S1 C) were un-
affected by depletion of CHC22, as were CLC protein levels 
(Fig. 1 C), corroborating no detectable biochemical interaction 
between CHC22 and CLCs or CHC17 (Liu et al., 2001). By 
comparison, depletion of CHC17 profoundly reduced CLC levels. 
Together, these depletion studies indicate that under endogenous 
conditions, CHC22 is outcompeted for localization to the TGN 
by CHC17.
Consistent with CHC22 showing no coimmunoprecipitation 
with the endocytic adaptor AP2 (Liu et al., 2001; Vassilopoulos 
et al., 2009), CHC22 was not observed at the plasma membrane, 
even in the absence of CHC17, and depletion of CHC22 had no 
effect on endocytosis of transferrin by HeLa cells (Fig. 1, D–F). 
These results correlated with no observed effect on EGF uptake 
after CHC22 depletion from LHCNM2 myoblasts (Vassilopoulos 
et al., 2009). In contrast, CHC17 depletion strongly inhibited 
transferrin endocytosis (Fig. 1, D–F), as described previously 
2007, 2009; Lim et al., 2008). Despite the described differences 
between CHCs, a recent study demonstrated that transfected 
CHC22 could rescue CHC17 function after CHC17 depletion by 
siRNA (Hood and Royle, 2009). This raised issues of CHC com-
petition and redundancy and whether a dominant pathway for 
endogenous CHC22 function can be defined.
GLUT4 is expressed in muscle and adipocytes, where it is 
concentrated in the insulin-regulated GLUT4 storage compart-
ment (GSC) and colocalizes with CHC22, which is involved in 
GSC formation (Vassilopoulos et al., 2009). Traffic to and from 
the GSC, derived from both the endocytic and secretory path-
ways, involves ubiquitous membrane traffic mediators includ-
ing SNAREs, AP1, GGAs, and CHC17 as well as some proteins 
with tissue-restricted expression (Hou and Pessin, 2007; Huang 
and Czech, 2007). GLUT4 itself shares ubiquitous trafficking 
pathways with endocytic and retrograde cargo in the endosomal 
system such as transferrin receptor and the cation-independent 
mannose-6-phosphate receptor (CI-MPR; Karylowski et al., 
2004; Huang and Czech, 2007). Hence, the CHC22 pathway 
contributing to GSC formation may be restricted to GSC-bound 
cargo but could also represent a ubiquitous trafficking pathway. 
Mapping the precise trafficking step where CHC22 operates 
and establishing the extent of its intracellular role characterizes 
a pathway that contributes to GSC formation, a process that has 
considerable relevance to type 2 diabetes, where GSC function 
is defective (Garvey et al., 1998; Maianu et al., 2001).
A notable feature of CHC22 is its absence from the Mus 
(murine) genome (Wakeham et al., 2005). Indeed, expression of 
human CHC22 in transgenic mice leads to a GLUT4 trafficking 
defect, resulting in features of diabetes (Vassilopoulos et al., 
2009). In addition to implicating CHC22 in GLUT4 trafficking, 
the transgenic mouse phenotype suggests the possibility that 
other species-restricted proteins involved in membrane traffic 
might function in concert with CHC22. Such trafficking proteins 
that are present in humans but not in mice include TBC1D3, a 
GGA-binding mediator of macropinocytosis (Frittoli et al., 2008; 
Wainszelbaum et al., 2008) and syntaxin 10 (STX10), a SNARE 
involved in retrograde endosomal sorting (Tang et al., 1998; 
Ganley et al., 2008). The studies reported here demonstrate that 
STX10 plays a role in GSC formation, establishing a connection 
between STX10 and CHC22 function and implicating endosomal 
traffic in GSC formation. Through analysis of the role of CHC22 
in sorting additional cargo in HeLa cells, we also establish that 
the two CHC isoforms indeed mediate distinct intracellular mem-
brane traffic pathways and that CHC22 function defines a novel 
step in endosomal sorting in nonmuscle cells. Finally, by demon-
strating a comparable function for CHC22 in skeletal muscle 
cells, we define a role for this pathway in GLUT4 trafficking.
Results
CHC22 function segregates from CHC17 
function and its localization is restricted  
to endosomes
We established both absolute and relative levels of endogenous 
expression of the two CHCs in different cell types, in order to 
understand the apparently discrepant results from studies 
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redundant function of the two CHCs occurs only if CHC17 is 
absent and CHC22 is highly overexpressed. Similar consider-
ations apply to CHC22 substitution for CHC17 function in mi-
totic spindle dynamics, as we did not detect CHC22 by antibody 
staining on spindles in either control cells or cells depleted of 
CHC17 (Fig. S1, F and G).
Lack of localization of CHC22 with TGN (perinuclear 
AP1, TGN46; Fig. S1 D, Fig. S2, A and B) and plasma mem-
brane markers (AP2; Fig. S2 C) prompted us to study CHC22 in 
the endosomal system where subpopulations of AP1 and AP3 
are present (Dell’Angelica et al., 1997; Meyer et al., 2000). 
CHC22 did not localize with early endosomal antigen EEA1 or 
recycling endosomal Rab11 (Fig. 3, A and B; Fig. S2, G and H), 
but partially overlapped with the late endosome marker Rab9 
(Fig. 3 C; quantified in Fig. S2, G and H). Lesser overlap was 
seen with AP3 (Fig. S2 E) and sorting nexins SNX5 (Fig. S2 D) 
and SNX1 (Fig. S2 F), which are present in endosomal sorting 
domains. Treatment of cells with Brefeldin A disrupted the char-
acteristic TGN localization of CHC17 (Wong and Brodsky, 
1992) but did not affect overall CHC22 distribution or CHC17 
distribution in endosomal regions (Fig. S3). Hence, endogenous 
CHC22 is confined to endosomes. We therefore tested a role for 
CHC22 in distinct endosomal sorting pathways defined by model 
cargo molecules.
(Hinrichsen et al., 2003; Motley et al., 2003). However, it was 
recently demonstrated that supertransfected CHC22 rescued 
endocytosis defects caused by CHC17 depletion (Hood and 
Royle, 2009). The GFP-CHC22 construct used in that study was 
driven by a CMV promotor, resulting in high expression. The 
compensation by CHC22 in the absence of CHC17 raised the 
question of whether higher-than-natural levels of CHC22 could 
compete for endogenous CHC17. To address this, we reproduced 
the CMV promoter-driven GFP-CHC22 construct, making sure 
it was full length and not missing the apparently labile exon 9 
(Hood and Royle, 2009). After transient transfection of HeLa 
cells, colocalization between CHC17 and CHC22 was assessed by 
antibody detection of both endogenous and artificially introduced 
protein, comparing nontransfected (Fig. 2 A) with transfected 
cells (Fig. 2 B) in the same culture. High levels of GFP-CHC22 
caused increased (three- to fourfold) colocalization of the two 
CHCs (Fig. 2 C). Thus, when CHC22 is expressed in excess, it 
can localize to the same cellular regions as CHC17. It is notable 
that neither the location nor intensity of CHC17 staining was 
altered by the presence of GFP-CHC22, suggesting that the 
introduced protein could not compete with endogenous CHC17 
when present. Furthermore, CHC22 does not compensate for 
CHC17 function if absent and CHC22 is expressed at its rela-
tively low endogenous levels (Fig. 1, D–F), so the apparently 
Figure 1. CHC22 is present at variable levels in most cell types and does not participate in endocytosis. (A) Detergent lysates of 10 tissue culture cell lines 
(equalized for protein content) were separated by SDS-PAGE and immunoblotted with antibodies against proteins indicated at the left. Tissue sources for 
the cell lines were cervical epithelium (HeLa), mammary gland epithelium (MDA 231), epidermal epithelium (A431), kidney epithelium (HEK 293), fore-
skin fibroblast (HFF), hepatocellular carcinoma (HepG2), natural killer lymphocyte (NKL), rhabdomyosarcoma (JR1), and skeletal muscle (LHCNM2 and 
C2C12), with all derived from human samples except C2C12 (mouse). (B) Indicated amounts of recombinant protein fragments (in ng) of CHC17 (amino 
acids 1–1074, CHC17-TDD) or CHC22 (amino acids 1521–1640, CHC22-TXD) and of detergent lysates (in µg) of HeLa or LHCNM2 cells (designated 
at the far right) were separated by SDS-PAGE and analyzed sequentially on the same immunoblot, after stripping in between, with antibodies against the 
CHC for the entire row indicated at the left. Below, each plot shows the intensity of the immunoblotting signal (x-axis) versus the amount of recombinant 
protein (left y-axis, solid squares) or detergent lysate (right y-axis, solid triangles) analyzed. CHC amount in cell lysates was determined by intersection 
with the immunoblotting signals from the recombinant fragments used for antibody calibration, adjusting for fragment length. Measured ratios for CHC22 
compared with CHC17 were 1:8 for LHCNM2 and 1:12 for HeLa. (C) Detergent lysates of HeLa cells treated with siRNA to deplete CHCs indicated at the 
top or with control siRNA were separated by SDS-PAGE and immunoblotted with antibodies against proteins indicated at the left. -Tubulin (-tub) serves as 
a loading control. (D–F) HeLa cells treated with control siRNA (D) or siRNA to deplete cells of CHC17 (E) and CHC22 (F) were incubated with fluorescent 
transferrin (green in merged insets) and internalization was allowed for 10 min. Cells were then fixed and processed for double immunofluorescence using 
antibodies against CHC17 (red in merged insets) or CHC22 (blue in merged insets) as indicated. Bars, 20 µm.
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CHC22 construct completely reversed the effects induced by 
siRNA targeting of CHC22 without affecting control-treated or 
CHC17-depleted cells (Fig. 4, C–F), further indicating that the 
two CHCs act at separate stages of CI-MPR transport. CHC-
depleted cells were tested for secretion of the lysosomal hydrolase 
hexosaminidase (Fig. 4 G), a hallmark of mis-sorting of CI-MPR 
at the TGN (Riederer et al., 1994). CHC17 and CHC22 loss 
resulted in a respective 70% or 22% increase of secreted hex-
osaminidase, with the considerably stronger effect of CHC17 
corroborating its role in sorting CI-MPR at the TGN. Simultane-
ous depletion of CHCs appeared to increase hexosaminidase 
secretion in an additive fashion, though not statistically sig-
nificant compared with CHC17 depletion alone, supporting 
roles for each CHC at distinct steps of CI-MPR traffic.
The punctate distribution of CI-MPR in CHC22-depleted 
cells suggested that it might be trapped in some stage of the 
endosomal pathway. Furthermore, CI-MPR did not colocalize 
with CHC17 in CHC22-depleted cells, indicating that CI-MPR 
was not present in the TGN upon loss of CHC22 (Fig. 5 B). 
CI-MPR sorting in the endosomal pathway requires CHC17 
and retromer for retrograde exit from EEA1-positive endosomes 
(Arighi et al., 2004; Saint-Pol et al., 2004; Seaman, 2004). Con-
sequently, CI-MPR showed increased colocalization with EEA1 
after depletion of CHC17 or SNX1 (Fig. 5, D and F; and quantified 
in Fig. 5 G). In contrast, CI-MPR did not display increased as-
sociation with EEA1 after CHC22 depletion (Fig. 5, E and G). 
EEA1 itself displayed little overall change in CHC22-depleted cells, 
although a tendency for tubulation of EEA1+ structures was noted. 
Thus, in endosomal sorting of CI-MPR, CHC22 appears to act 
downstream of early endosome exit and separately from CHC17.
CHC17 and CHC22 act independently in 
endosomal sorting
Previous studies using dominant-negative constructs of the two 
CHCs representing the C-terminal third (Hub) of each protein 
suggested that they are both involved in CI-MPR localization. 
The CHC22 Hub caused dispersion of the CI-MPR from its nor-
mal perinuclear focus (Liu et al., 2001) and the CHC17 Hub 
induced a tighter perinuclear distribution than normal (Bennett 
et al., 2001). In the present study, similar effects were observed 
after treatment of HeLa cells with siRNAs targeting each CHC 
(Fig. 4). In comparison to the loose perinuclear concentration of 
CI-MPR in late endosomes in control cells (Fig. 4, A and C; Fig. 5, 
A and C), CHC17 depletion induced a slightly tighter peri-
nuclear concentration, as reported previously (Hinrichsen et al., 
2003; Fig. 4 D, Fig. 5 D). In contrast, after CHC22 depletion, 
CI-MPR was quantitatively more dispersed throughout the cyto-
sol in small vesicular structures (Fig. 4, B, E and F; Fig. 5, B 
and E), as assessed by measuring levels of CI-MPR peripheral to 
the Golgi region (see illustrative Fig. S4). Expression of an 
siRNA-resistant (knock-down proof [KDP]), FLAG-tagged 
Figure 2. Overexpression of CHC22 increases its colocalization with 
CHC17. (A and B) HeLa cells transfected with GFP-tagged CHC22 (GFP-
CHC22, blue in merged insets) were processed for immunofluorescence 
and labeled for CHC17 (green in merged insets) and CHC22 (red in 
merged insets) as indicated. CHC22 label was imaged with microscope 
settings optimal for nontransfected cells (A) or transfected cells (B). Merged 
images of the boxed area consisting of CHC17 and CHC22 antibody 
labeling in the middle panels and all three signals in the right images are 
presented as an inset. Bars, 20 µm. (C) Vesicles containing both CHC17 
and CHC22 or CHC22 only were automatically counted in nontransfected 
(no GFP) or transfected cells (GFP-CHC22). The percentage of vesicles con-
taining both CHCs relative to all CHC22-positive vesicles is plotted (black 
bars) against the left y-axis for individual cells (n = 12 each of transfected 
or nontransfected cells from two independent experiments). Average per-
centages are shown ± SEM. Pearson’s coefficients of colocalization were 
determined for cells from the same experiment and plotted ± SEM (gray 
bars) against the right y-axis (n = 12 each of transfected or nontransfected 
cells from two independent experiments). P-values for respective evaluation 
are indicated according to color code.
Figure 3. CHC22 partially colocalizes with the endosomal marker Rab9. 
HeLa cells were grown on coverslips, processed for immunofluorescence, 
and labeled for CHC22 (red in merged insets). Simultaneous labeling was 
performed (green in merged insets) using mouse monoclonal antibodies 
against (A) EEA1 and (C) Rab9. (B) Rab11 was visualized as a GFP fusion 
protein after transient transfection of HeLa cells. Bars, 20 µm.
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than doubled compared with its normal distribution in all three 
depletion conditions (Fig. 7 E). However, in CHC22-depleted 
cells, STxB was less colocalized with EEA1 (Fig. 7, C and F) 
than in cells depleted for CHC17 or SNX1 (Fig. 7, B, D, and F). 
Increased colocalization between STxB and EEA1 in CHC17- 
or SNX1-depleted cells was as expected, based on previous stud-
ies (Saint-Pol et al., 2004; Popoff et al., 2007). Thus, depletion 
of CHC22 did not affect STxB exit from the early endosome, 
where STxB was localized after 15 min of uptake (Fig. S5, A–D) 
and is sorted by CHC17 and SNX1. Instead, CHC22 depletion 
interfered with a later sorting step needed for endosome-to-TGN 
traffic of STxB, separating it from CHC17 function in this path-
way, as well as in CI-MPR transport.
Examination of STxB, CI-MPR, and EEA1 together (Fig. 8) 
confirmed that both cargoes were able to transit from early endo-
somes after CHC22 depletion and were colocalized in a com-
partment (Fig. 8, C and E) with less EEA1 (Fig. 5 G and Fig. 7 F) 
compared with their localization after depletion of CHC17 or 
SNX1. After SNX1 depletion, both cargoes were colocalized with 
each other to the same extent as seen with CHC22 depletion 
(Fig. 8, D and E), but were increasingly localized with EEA1 
(Fig. 5 G and Fig. 7 F), reflecting a common dependence on 
SNX1 for early endosome exit. CHC17 depletion, on the other 
hand, differentially affected the two cargoes. CI-MPR and STxB 
were less colocalized after CHC17 depletion than after CHC22 
or SNX1 depletion (Fig. 8, B and E), and there was more over-
lap between STxB and EEA1 than between CI-MPR and EEA1 
in CHC17-depleted cells (Fig. 7 F and Fig. 5 G). This can be 
In contrast to CI-MPR cycling, TGN46 traffics rapidly from 
early endosomes to the TGN via recycling endosomes (Banting 
et al., 1998; Ganley et al., 2008; Nokes et al., 2008). This results 
in steady-state perinuclear accumulation in control cells (Fig. 6 A). 
TGN46 localization was not affected in CHC22-depleted cells 
(Fig. 6 C), whereas loss of CHC17 resulted in diminished and 
dispersed TGN46 labeling. This phenotype suggested retention 
of TGN46 in early endosomes and subsequent degradation in 
cells depleted of CHC17, correlating with reduced protein 
levels in these cells (Fig. 6 D). Thus, dependence of TGN46 
traffic on CHC17 and independence from CHC22 function fur-
ther distinguishes trafficking steps mediated by the two CHCs.
Shiga toxin B-subunit (STxB) serves as a model cargo for 
early endosome-to-TGN trafficking. Upon clathrin-independent 
entry into cells, STxB transits EEA1-positive early endosomes 
where it is sequentially sorted in CHC17- and retromer-dependent 
steps, before it is targeted to the TGN (Saint-Pol et al., 2004; 
Bujny et al., 2007; Popoff et al., 2007; Johannes and Popoff, 2008). 
In cells depleted of either CHC or SNX1, or in cells treated with 
control siRNA, STxB internalized for 15 min was colocalized 
with EEA1 (Fig. S5, A–D), indicating no defect in plasma mem-
brane uptake. After 60 min of uptake, STxB showed perinuclear 
localization in control-treated cells (Fig. 7 A, Fig. S5 E), repro-
ducing described kinetics for TGN arrival (Mallard et al., 1998). 
In cells depleted for either CHC or SNX1, STxB was more dis-
perse, as though its retrograde transport to the TGN was impaired 
(Fig. 7, B–D, Fig. S5, F–H). Quantification of proximity to 
GM130 showed that peripheral STxB localization was more 
Figure 4. CHC22 depletion leads to dispersal of CI-
MPR from the perinuclear region. (A and B) HeLa cells 
treated with control siRNA (A) or siRNA to deplete 
CHC22 (B) were processed for immunofluorescence 
and labeled for CI-MPR (green in merged insets) and 
CHC22 (red in merged insets) as indicated. Bars, 
20 µm. (C–E) HeLa cells treated with control siRNA 
(C) or siRNA to deplete CHC17 (D) and CHC22 
(E) were transfected with an siRNA-resistant, FLAG-
tagged CHC22 construct (CHC22-KDP, knock-down 
proof), processed for immunofluorescence, and labeled 
for CI-MPR, FLAG-tag, and GM130 as indicated. In E, 
an asterisk marks a cell transfected with CHC22-KDP 
and siRNA targeting CHC22 that exhibits a normal 
concentration of CI-MPR in the perinuclear region, 
whereas an adjacent cell without CHC22-KDP (arrow-
head) has dispersed CI-MPR, as in B. Bars, 20 µm. 
(F) For cells treated as in C–E, peripheral CI-MPR 
was quantified around the Golgi region (labeled with 
GM130) as a percentage of total CI-MPR, using the 
method illustrated in Fig. S4 (control cells: n = 12 
for transfected and nontransfected; CHC17-depleted 
cells: n = 7 for nontransfected, n = 12 for transfected; 
CHC22-depleted cells: n = 16 for nontransfected, 
n = 17 for transfected; all cells from two independent 
experiments). Average percentages were plotted ± 
SEM. P-values for selected samples are indicated. 
(G) HeLa cells were treated with siRNAs against 
CHC17, CHC22, or a combination, or with control 
siRNA, as indicated below each bar, and hexosa-
minidase (Hex) activity was measured. Depicted is the 
ratio of extracellular to intracellular hexosaminidase 
activity for each treatment condition normalized to 
the ratio measured for control-treated cells in each ex-
periment (n = 5, ±SEM shown). P-values for selected 
samples are indicated.
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CHC22 plays a role in endosomal sorting in 
human myoblasts
Having localized CHC22 function to a distinct sorting step in 
the endosomal pathway in nonmuscle cells, it was of interest to 
determine if CHC22 plays the same role in myoblasts. In doing 
so, the issue of whether CHC22-dependent endosomal sorting is 
an important step in GLUT4 sequestration in the GSC is addressed 
(Hou and Pessin, 2007; Huang and Czech, 2007; Vassilopoulos 
et al., 2009). The human myoblast cell line LHCNM2 has a 
1.5-fold higher ratio of CHC22 expression relative to CHC17 
than HeLa (Fig. 1 B), and differentiates into myotubes, like 
the commonly studied rodent myoblast lines C2C12 and L6 
explained by a requirement for CHC17 in CI-MPR exit from the 
TGN that has been previously demonstrated (Hinrichsen et al., 
2003). Thus, CHC22 function is required after early endosome 
exit of either cargo and before the divergence of STxB from 
CI-MPR on their respective routes to the TGN from endosomes. 
In complete distinction, CHC17 function is critical for CI-MPR 
export from the TGN, sorting of STxB (and some CI-MPR, e.g., 
Fig. 5 G) out of early endosomes, and recycling of TGN46 from 
endosomes to the TGN (Fig. 6). The CHC22-dependent step 
that commonly affects CI-MPR and STxB before their known 
retrograde divergence subdivides retrograde sorting, defining a 
novel stage in the endosomal transport pathway.
Figure 5. Dispersed CI-MPR shows less association 
with early endosomes upon CHC22 depletion than 
after CHC17 or SNX1 depletion. (A and B) HeLa cells 
treated with control siRNA (A) or siRNA targeting 
CHC22 (B) were processed for immunofluorescence 
and labeled using antibodies against CI-MPR (green 
in merged insets) and CHC17 (red in merged insets) 
as indicated. (C–F) Examples of cells quantified in G. 
HeLa cells treated with control siRNA (C) or siRNA 
to deplete cells of CHC17 (D), CHC22 (E), or SNX1 
(F) were processed for immunofluorescence and labeled 
using antibodies against EEA1 (green in merged in-
sets) and CI-MPR (red in merged insets) as indicated. 
Bars, 20 µm. (G) Vesicles containing both CI-MPR and 
EEA1 or only CI-MPR in cells depleted of the indicated 
proteins were automatically counted. The percentage 
of vesicles with double labeling was calculated relative 
to all vesicles containing CI-MPR for individual cells 
(n = 15 for control, n = 20 for CHC17-depleted, n = 25 
for CHC22-depleted, n = 16 for SNX1-depleted cells; 
cells from two independent experiments). Average 
percentages ± SEM are shown in black against the 
left y-axis. Pearson coefficients of colocalization were 
determined for individual cells from the same experi-
ments and plotted ± SEM (gray bars) against the right 
y-axis (n = 12 for each control and depletion condi-
tion, derived from two independent experiments). 
P-values for selected evaluation are indicated accord-
ing to color code.
Figure 6. CHC17 but not CHC22 depletion affects 
TGN46 distribution and trafficking. (A–C) HeLa cells 
treated with control siRNA (A) or siRNA to deplete 
CHC17 (B) or CHC22 (C) were processed for immuno-
fluorescence and labeled using antibodies against 
TGN46 (green in merged insets) and CHC17 (red in 
merged insets) as indicated. Bars, 20 µm. (D) Deter-
gent lysates of HeLa cells treated with control siRNA or 
siRNA to deplete CHC17 or CHC22 as indicated at 
the top were separated by SDS-PAGE and immuno-
blotted with antibodies against the proteins indicated 
at the left. -Actin serves as loading control.
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(Zhu et al., 2007). Depletion of CHC22 or CHC17 from 
LHCNM2-derived myotubes (Fig. 9, A–D) had similar effects 
to those observed for HeLa cells (Fig. 5). In myotubes depleted 
of CHC22, CI-MPR was dispersed compared with its peri-
nuclear focus around myonuclei in control-treated myotubes. This 
strong CI-MPR association with myonuclei made it hard to 
quantify a qualitatively denser appearance upon CHC17 deple-
tion. However CI-MPR labeling was clearly different in myo-
tubes depleted for each CHC and, as seen for HeLa cells, a 
slight increase in CHC22 protein level was observed in CHC17-
depleted cells (Fig. 9 E). CI-MPR-levels were decreased to 83% 
and 61% of control cells after depletion of CHC17 or CHC22, 
respectively (Fig. 9, E and F), confirming a role for both CHCs 
in influencing endosomal sorting of CI-MPR in myotubes. To 
address whether CHCs function at different steps of CI-MPR 
sorting, as in HeLa cells, processing of the CI-MPR–transported 
lysosomal hydrolase, Cathepsin D, was analyzed. Upon exiting 
the TGN as an immature protein (pro, 53 kD) bound to CI-MPR, 
Cathepsin D enters the endocytic pathway where it is proteolyt-
ically processed to an intermediate (pre) form (47 kD) and then 
into a mature form (31 kD). Levels of these Cathepsin D forms 
may be used to assess trafficking toward the lysosome (Mardones 
et al., 2007). After CHC22 depletion, the amount of intermedi-
ate (pre) form was increased (Fig. 9, E and G), indicative of 
Cathepsin D accumulation with CI-MPR in an intermediate 
endocytic compartment. This effect was not observed upon 
CHC17 depletion, consistent with the limited effect of CHC17 
depletion on CI-MPR in muscle cells. Thus, CHC22 plays a role 
in endosomal sorting in muscle cells that is distinct from func-
tions of CHC17, and is implicated in the same functional path-
way as was mapped for CHC22 in HeLa cells.
GLUT4 targeting to the GSC in human muscle depends 
on CHC22 (Vassilopoulos et al., 2009), and the studies reported 
here map CHC22 function in muscle to retrograde endosomal 
transport. In mice, which normally do not express CHC22, trans-
genically introduced CHC22 interacts with adaptors responsible 
for GLUT4 transport and disrupts murine GLUT4 traffic such 
that the formation and function of the GSC is impaired. It is 
conceivable that for CHC22 to function as it does in humans, 
additional species-specific factors are needed to complete its 
role in GSC formation (Vassilopoulos et al., 2009). An obvious 
candidate for such a factor is the SNARE family protein STX10, 
which plays a role in retrograde transport of CI-MPR from endo-
somes to the TGN, is enriched in muscle, and is expressed in 
humans but not mice (Tang et al., 1998; Ganley et al., 2008). 
The effects of STX10 depletion on GLUT4 traffic in human myo-
blasts were therefore assessed (Fig. 10) and found to phenocopy 
CHC22 depletion, causing dispersion and loss of GLUT4 stain-
ing (Fig. 10, B–D). As seen previously, STX10 depletion also 
caused dispersion of the CI-MPR in HeLa cells (Fig. 10 F), but 
it did not affect retrograde transport of STxB (Fig. 10 G; Mallard 
et al., 2002; Ganley et al., 2008). Again, phenocopying CHC22 
(Vassilopoulos et al., 2009), STX10 depletion slightly reduced 
total GLUT4 levels in myotubes (Fig. 10, H and I), indicating 
that GLUT4 was partially degraded when GSC formation was 
disrupted. Localization of CHC22 was not severely affected in 
cells depleted of STX10 (Fig. 9 A, Fig. 10 C), whereas CHC22 
Figure 7. Depletion of CHC17, CHC22, or SNX1 affects STxB trafficking. 
(A–D) HeLa cells were treated with control siRNA (A) or siRNA to deplete 
cells of CHC17 (B), CHC22 (C), or SNX1 (D). Fluorescent STxB (red in 
merged insets) in fresh medium was bound to cells for 30 min on ice, 
washed in PBS, and chased for 60 min in fresh medium at 37°C. Cells 
were fixed, processed for immunofluorescence, and labeled using antibod-
ies against EEA1 (green in merged insets) and GM130 (blue in merged 
insets). Bars, 20 µm. (E) Peripheral STxB signal around the Golgi (detected 
by GM130 labeling) was determined in cells treated as in A–D. Peripheral 
signals were calculated as percentages of total signal from individual cells 
using the method illustrated in Fig. S4 (n = 20 each for control, CHC17-
depleted, CHC22-depleted, and SNX1-depleted cells; cells from two in-
dependent experiments) and average percentages were plotted ± SEM. 
P-values for selected samples are indicated. (F) Vesicles containing both 
STxB and EEA1 or only STxB in cells depleted of the indicated proteins were 
automatically counted. The percentage of vesicles containing double label-
ing relative to all vesicles containing STxB was calculated for individual cells 
(n = 15 for control, n = 20 for CHC17-depleted, n = 25 for CHC22- 
depleted, n = 16 for SNX1-depleted cells; cells from two independent experi-
ments). Average percentages are shown ± SEM in black against the left 
y-axis. Pearson’s coefficients of colocalization were determined for cells 
from the same experiments and plotted ± SEM (gray bars) against the right 
y-axis (n = 12 for the control and each of the depletion conditions from two 
independent experiments). P-values for selected evaluation are indicated 
according to color code.
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needed for endosomal sorting of both exogenous (STxB) and 
endogenous (CI-MPR, GLUT4) vesicle cargo. This localizes the 
normal intracellular function of CHC22, which is completely 
distinct from that of CHC17, and defines a novel stage in retro-
grade endosome-to-TGN sorting.
CHC17 and CHC22 sequences differ in key functional 
regions mediating CLC association and adaptor interactions 
(Wakeham et al., 2005), such that endogenous CHC22 does not 
bind either AP2 or CLCs in cells. Instead, the region that binds 
CLCs in CHC17 mediates SNX5 interaction for CHC22 (Liu 
et al., 2001; Towler et al., 2004; Vassilopoulos et al., 2009). Deple-
tion of each CHC leads to completely different phenotypes with 
respect to endosomal sorting, TGN sorting, and endocytosis 
(Figs. 1, 4–8, and Fig. S5) in Hela cells and additionally GSC 
formation in skeletal muscle (Fig. 9 and Fig. 10; Vassilopoulos 
et al., 2009). Sequence divergence between CHCs is not solely 
responsible for their functional divergence, as abnormally high 
levels of CHC22 may rescue CHC17 function when CHC17 is 
depleted (Hood and Royle, 2009). However, endogenous CHC22 
depletion led to some dispersion of STX10 (Fig. 10, A and D). 
This suggests that CHC22 acts upstream of STX10 in endosomal 
sorting, consistent with CHC22 depletion affecting all three car-
goes but STX10 depletion affecting only CI-MPR and GLUT4, 
but not STxB trafficking. Targeting STxB to the TGN must pre-
cede that of the other two cargoes, further subdividing retrograde 
transport from endosomes to TGN into two steps that follow a 
novel CHC22-dependent step. These data, which establish the 
joint participation of CHC22 and STX10 in GLUT4 traffic, map 
endosomal sorting and retrograde endosome-to-TGN transport 
as critical steps in GSC formation in human tissue.
Discussion
In this study we define the membrane-trafficking function of 
CHC22, a second isoform of the clathrin heavy chain, which is 
present in humans in addition to the CHC17 isoform. We found 
that CHC22 is expressed at variable levels in all human cells 
studied and establish that CHC22 has a ubiquitous function 
Figure 8. Retrograde traffic of STxB and CI-MPR 
from endosome to TGN is differentially impaired in 
CHC17-, CHC22-, and SNX1-depleted cells. (A–D) 
HeLa cells were treated with control siRNA (A) or 
siRNA targeting CHC17 (B), CHC22 (C), or SNX1 
(D). Fluorescent STxB (red in merged insets) in fresh 
medium was bound to cells for 30 min on ice, washed 
in PBS, and chased for 60 min in fresh medium at 
37°C. Cells were fixed, processed for immunofluores-
cence, and labeled using antibodies against CI-MPR 
(green in merged insets) and EEA1 (blue in merged 
insets). Bars, 20 µm. (E) Vesicles containing both STxB 
and CI-MPR or STxB only were automatically counted 
in cells depleted of the indicated proteins. The percent-
age of vesicles containing double labeling relative to 
all vesicles containing STxB was calculated for indi-
vidual cells (n = 15 for control, n = 20 for CHC17-
depleted, n = 25 for CHC22-depleted, n = 16 for 
SNX1-depleted cells; cells from two independent ex-
periments). Average percentages are shown ± SEM 
in black against the left y-axis. Pearson’s coefficients 
of colocalization were determined for cells from the 
same experiments and plotted ± SEM (gray bars) 
against the right y-axis (n = 12 for the control and 
each of the depletion conditions from two indepen-
dent experiments). P-values for selected evaluation are 
indicated according to color code.
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endosomal membranes (Ganley et al., 2008), likely functions 
downstream of CHC22 in retrograde transport (Fig. 10). Collec-
tively, the data presented here indicate a sequential sorting pro-
cess for CI-MPR and STxB involving first CHC17 and retromer 
mediating exit of both cargoes from the early endosome, then 
requiring CHC22 function for a later retrograde sorting step 
affecting both STxB and CI-MPR. At this point, divergence of 
STxB and CI-MPR occurs with STxB directly trafficking to the 
TGN, but CI-MPR requiring subsequent STX10 and Rab9 func-
tions for retrograde transport. Thus, CHC22-mediated sorting 
defines a novel intermediate stage of retrograde sorting that in-
fluences the fate of multiple cargoes and does not overlap with 
CHC17 function.
Retrograde sorting from the endocytic pathway requires 
tubulation from early endosomes, dependent on dynactin, CHC17, 
and recruitment of retromer (Popoff et al., 2007; He et al., 2008; 
Rojas et al., 2008; Seaman et al., 2009; Wassmer et al., 2009). 
We propose that like CHC17, CHC22 function may also involve 
retromer. SNX5, a component of the retromer complex, can bind 
CHC22 and is detected on the tubular sorting compartment from 
which later retrograde transport involving CHC22 would emerge 
(Wassmer et al., 2009). CHC22 could be actively sorting cargo 
or mediate a sorting step that influences compartment composi-
tion and thereby affects its function, analogous to the role 
defined for CHC17 (Arighi et al., 2004; Saint-Pol et al., 2004; 
Seaman, 2004; Bujny et al., 2007; Popoff et al., 2007; Johannes 
and Popoff, 2008). Despite our best efforts, it has not yet been 
possible to localize endogenous CHC22 by electron microscopy 
to establish whether it is primarily associated with tubules, ves-
icles, or larger endocytic compartments. We did, however, observe 
that depletion of CHC22 increased endosome tubulation (Fig. 5 E) 
and previously observed that transfected CHC22 localized to 
protein levels are at least eightfold lower than CHC17 levels in 
cells (Fig. 1), such that complete functional separation is ensured. 
Even in the context of variable CHC17 surplus, CHC22 binds 
its own subset of AP1 and AP3 adaptors on endosomes, possi-
bly assisted by SNX5 or GGA interaction (Fig. 3; Figs. S1–S3) 
(Towler et al., 2004; Vassilopoulos et al., 2009). Hence, the 
segregation of CHC functions that emerged after gene duplica-
tion (Wakeham et al., 2005) is dictated by their sequence 
divergence as well as their relative concentration in cells, such 
that CHC22 cannot outcompete CHC17 but also has its own 
unique interactions.
The studies reported here demonstrate that CHC22 func-
tion is required for endosomal sorting that occurs after the 
CHC17-dependent step required for retrograde cargo exit from 
early endosomes (Saint-Pol et al., 2004) and early retrograde 
transport of TGN46 (Figs. 4–8). CHC17 and the retromer com-
plex act sequentially in STxB export from the early endosome 
to later stages of the retrograde pathway and are proposed to 
play the same role for CI-MPR (Johannes and Popoff, 2008). 
Accordingly, for both cargoes, depletion of the retromer com-
ponent SNX1 had a similar phenotype to CHC17 depletion but 
different from CHC22 depletion, placing CHC22 downstream 
of this particular retromer function. STxB does not progress to 
the lumen of late endosomes before its retrograde transport to 
the TGN (Mallard et al., 1998; Saint-Pol et al., 2004), whereas 
CI-MPR at least partially does (Lombardi et al., 1993; Ganley 
et al., 2008; Seaman et al., 2009). The accumulation of CI-MPR 
and STxB in the same compartment in cells depleted of CHC22 
suggests that these two cargoes exit early endosomes together 
and that subsequent CHC22-dependent traffic and/or sorting 
occurs before they diverge. The SNARE family member STX10, 
which has been implicated in fusion processes at both TGN and 
Figure 9. Effects of CHC17 and CHC22 down-regulation 
on CI-MPR trafficking in human myoblasts reproduce 
effects in HeLa cells. (A–D) LHCNM2 human skeletal 
muscle myoblasts were differentiated, treated with con-
trol siRNA (A and C) or siRNA targeting CHC22 (B) or 
CHC17 (D) and processed for immunofluorescence. 
Cells were double labeled using antibodies against 
CHC17 (green in merged insets), CHC22 (green in 
merged insets), and CI-MPR (red in merged insets) as 
indicated. Bars, 20 µm. (E) LHCNM2 cells were dif-
ferentiated and treated with siRNA targeting CHC17 
or CHC22 or control siRNA as indicated at the top 
of each lane. Whole-cell detergent lysates were sepa-
rated by SDS-PAGE and immunoblotted with antibod-
ies against the proteins indicated at the left. Immature 
(pro), intermediate (pre), and mature (mat) forms of 
Cathepsin D are indicated at the left. -Actin serves 
as a loading control. (F) Quantification of CI-MPR lev-
els in whole-cell detergent lysates from siRNA-treated 
cells generated as in E. Shown are levels ± SEM 
in the samples treated with the specific siRNA indi-
cated under each bar compared with levels in cells 
treated with control siRNA in the same experiment 
(n = 5). P-values for selected samples are indicated. 
(G) Quantification of preCathepsin D levels in whole-
cell detergent lysates from siRNA treated cells gener-
ated as in E. Shown are levels ± SEM in the samples 
treated with the specific siRNA indicated under each 
bar compared with levels in cells treated with control 
siRNA in the same experiment (n = 5). P-values for 
selected samples are indicated.
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membrane traffic in other cell types. While playing a role in 
nonmuscle cells, both CHC22 and STX10 are enriched in muscle 
(Fig. 1; Sirotkin et al., 1996; Tang et al., 1998), likely contributing 
to specialization of the GLUT4-trafficking pathway. Although 
showing similar tissue distribution and species restriction, as 
well as shared depletion phenotypes with respect to CI-MPR 
and GLUT4 targeting, CHC22 and STX10 differ in their contri-
bution to STxB trafficking. STX10 depletion does not affect 
STxB transport and a slight but detectable effect of CHC22 
depletion on STX10 localization places STX10 downstream of 
CHC22 function in retrograde sorting. These findings suggest 
that CHC22 function is required for STX10 targeting and sorting. 
Additionally, the SNARE STX10 may be required for fusion of 
GLUT4-containing vesicles that are formed as a result of CHC22 
function. Indeed, transgenic mice expressing human CHC22 
(without STX10) accumulate membrane compartments filled 
with GLUT4, which apparently do not fuse with target mem-
branes, leading to a dampened insulin response in these animals 
(Vassilopoulos et al., 2009).
The remarkable absence of both CHC22 and STX10 from 
the mouse genome (Wakeham et al., 2005; Ganley et al., 2008) 
has the consequence that GLUT4 traffic differs in humans and 
vesicles in the TGN (Liu et al., 2001). Notably, our data indicate 
that formation of the compartment where CHC22 functions de-
pends on CHC17 function early in the endocytic pathway. This 
explains why proteomic analysis of vesicle proteins that dis-
appear from membrane preparations after CHC17 depletion in-
cluded CHC22 (Borner et al., 2006).
The membrane traffic of GLUT4 to the insulin-regulatable 
GSC and CHC contribution to GSC formation has been charac-
terized in rodent and human muscle and fat cells (Shewan et al., 
2003; Karylowski et al., 2004; Li and Kandror, 2005; Hou and 
Pessin, 2007; Huang and Czech, 2007; Antonescu et al., 2008; 
Williams and Pessin, 2008; Fazakerley et al., 2009; Vassilopoulos 
et al., 2009). Here, we demonstrate that CHC22, in conjunction 
with STX10, influences retrograde transport and in human skeletal 
muscle both proteins contribute to GSC formation. Although 
our findings show that endosomal sorting and a retrograde 
endosome–TGN pathway are critical for human GSC forma-
tion, they cannot definitively answer whether, after CHC22 and 
STX10 action, GLUT4 is trafficked to the GSC via the TGN or 
from an endosomal compartment.
The GLUT4 pathway, although restricted to muscle and 
fat, depends on ubiquitously expressed molecules that mediate 
Figure 10. Syntaxin 10 depletion partially pheno-
copies CHC22 depletion and is implicated in GLUT4 
sequestration. (A–D) LHCNM2 human skeletal muscle 
myoblasts were differentiated, treated with control 
siRNA (A) or siRNA targeting STX10 (B and C) or 
CHC22 (D), and processed for immunofluorescence. 
Cells were double labeled using antibodies against 
STX10 (A, B, and D; green in merged insets), CHC22 
(C; green in merged inset), and GLUT4 (red in merged 
insets) as indicated. Bars, 20 µm. (E–G) HeLa cells 
treated with control siRNA (E) or siRNA to deplete 
STX10 (F and G) levels were processed for immuno-
fluorescence and labeled for STX10 (E and F; green 
in merged insets) and CI-MPR (E and F; red in merged 
insets) as indicated at the top. In G, fluorescent STxB 
(red in merged inset) in fresh medium was bound to 
cells for 30 min on ice, washed in PBS and chased 
for 60 min in fresh medium at 37°C, fixed, and 
processed for immunofluorescence using antibodies 
against GM130 (green in merged insets). (H) Deter-
gent lysates of LHCNM2 cells treated with siRNA to 
deplete CHC17, CHC22, or STX10 or with control 
siRNA as indicated at the top were separated by SDS-
PAGE and immunoblotted with antibodies against the 
proteins indicated at the left. -Tubulin (-tub) serves 
as a loading control. (I) Quantification of GLUT4 lev-
els in detergent lysates of siRNA-treated cells gener-
ated as in H. Shown are levels ± SEM in the samples 
treated with the specific siRNA indicated under each 
bar compared with levels in cells treated with control 
siRNA in the same experiment (n = 6). P-values for 
selected samples are indicated.
141Clathrin isotype function in endosomes • Esk et al.
was used, and the depletion efficiency was comparable to results using the 
siRNA mixture, as judged by immunoblotting whole-cell detergent lysates.
Cell culture
HeLa 229, MDA231, A431, HEK 293, HFF, HepG2, JR1, and C2C12 cells 
were grown in DME supplemented with 10% FBS, 50 U/ml penicillin, 
50 µg/ml streptomycin, and 0.625 µg/ml fungizone. NKL natural killer cells 
were grown in RPMI 1640 supplemented with 10% FBS, 200 U/ml IL2, 
50 U/ml penicillin, and 50 µg/ml streptomycin. LHCNM2 human skeletal 
muscle cells (Zhu et al., 2007) were maintained in tissue culture flasks coated 
with rat-tail collagen in basal medium (4:1 DME/M199, 0.02 M Hepes, 
0.03 µg/ml ZnSO4, and 1.4 µg/ml vitamin B12) with 15% fetal bovine 
serum (FBS), 55 ng/ml dexamethasone, 2.5 ng/ml hepatocyte growth factor 
(Sigma-Aldrich), 50 U/ml penicillin, 50 µg/ml streptomycin, and 0.625 µg/ml 
fungizone (growth medium). Differentiation was induced by culturing in 
fusion medium (basal medium with 0.5% FBS, 10 µg/ml insulin, 50 µg/ml 
apo-transferrin, and 5.5 ng/ml dexamethasone) followed by differentiation 
medium (basal medium with 0.5% FBS and 55 ng/ml dexamethasone).
Cells were transfected with 10 nM siRNA using HiPerfect (QIAGEN) 
according to the manufacturer’s instructions. HeLa cells were split, reseeded 
24 h after transfection, and retreated with siRNA 24 h later. Cells were 
used for experimentation 48–72 h after the second round of transfection. 
LHCNM2 cells were transfected twice, 72 h apart, and used 72 h later. For 
plasmid transfection Lipofectamine 2000 (Invitrogen) was used according 
to the manufacturer’s instructions 24 h before analysis of transfected cells.
Internalization assays
For internalization assays cells were grown on coverslips and transfected 
with siRNA as described above. STxB uptake was performed as described 
previously (Popoff et al., 2007). In brief, cells were washed twice in cold 
PBS on ice and incubated on ice in prechilled medium containing 2 µg/ml 
STxB coupled to Cy3 for 30 min. Cells were then washed twice in cold PBS 
on ice and taken off ice. Warm media was added and cells were incu-
bated at 37°C for various times before fixation. For transferrin internaliza-
tion, cells were washed twice in warm PBS and preincubated for 45 min at 
37°C in DME supplemented with 0.02M Hepes and 1% BSA (serum-free 
media [SFM]) to allow for recycling of the intracellular receptor. Cells were 
then washed twice in cold PBS on ice and incubated on ice for 30 min in 
prechilled SFM containing 10 µg/ml transferrin coupled to Alexa Fluor 
488 (Invitrogen). After washing twice in cold PBS on ice, cells were taken 
off ice and warm medium was added. Cells were then incubated at 37°C 
for 10 min before fixation.
Hexosaminidase secretion
Hexosaminidase secretion was measured using a protocol modified from 
one described previously (Riederer et al., 1994). Cells treated with siRNA 
as described above were washed in PBS and incubated in DME supple-
mented with 10 mM mannose-6-phosphate for 8 h at 37°C. Secreted hex-
osaminidase activity was assayed in 0.5 ml medium by addition of 120 µl 
5x hexosaminidase substrate buffer (0.5 M sodium acetate, pH 4.4, 0.5% 
Triton X-100, and 5 mM p-nitrophenyl-N-acetyl--d-glucosaminide). After 
shaking at 37°C for 1 h, reactions were stopped by addition of 0.6 ml 
stop buffer (0.5 M glycine and 0.5 M Na2CO3, pH 10.0). Release of 
p-nitrophenol was measured spectrophotometrically at 405 nm. Intracellular 
hexosaminidase was measured by washing the cells twice in cold scrap-
ing buffer (10 mM phosphate buffer, pH 6.0, and 0.15 M NaCl) and then 
scraping them into scraping buffer supplemented with 0.5% Triton X-100. 
After centrifugation at 100,000 g for 15 min at 4°C, 50 µl of the resulting 
supernatant was assayed in 570 µl 1x hexosaminidase substrate buffer. 
Secreted hexosaminidase was determined as the percentage of the total 
hexosaminidase for each sample (extracellular plus intracellular). Secreted 
hexosaminidase of samples treated with specific siRNA was then com-
pared with that of samples treated with control siRNA and ratios were cal-
culated. P-values were calculated using unpaired two-tailed Student’s t test.
Immunoblotting
Protein samples were separated by SDS-PAGE (4–12% acrylamide gel; Invit-
rogen), transferred to nitrocellulose (Millipore) and labeled with primary 
antibodies at 1–5 µg/ml and peroxidase-conjugated secondary antibodies. 
The presence of antibody-labeled proteins in samples was detected using 
Western Lightning Chemiluminescence Reagent (GE Healthcare). Rainbow 
molecular weight markers (GE Healthcare) were used to assess transfer 
efficiency and judge protein sizes. The migration positions of molecular 
weight marker proteins are indicated in kilodaltons (kD) at the right of each 
blot presented. Quantification was performed using Quantity One software 
(Bio-Rad Laboratories). To calibrate antibody blotting signals for quantification 
mice. The basic pathways and sorting signals for GLUT4 traf-
ficking are likely to be the same in the two species, but the pres-
ence of CHC22 and STX10 apparently modulates the balance 
between compartments where GLUT4 resides, and thereby 
influences the degree of GLUT4 sequestration in the GSC. Con-
sistent with less efficient GSC formation, mice display character-
istic differences in their glucose homeostasis compared with 
humans. After a meal, the main pathway for glucose uptake in 
humans is through the insulin-regulatable GLUT4 pathway in 
skeletal muscle, whereas mice rely more heavily on insulin-
stimulated reduction of glucose release from the liver (Brüning 
et al., 1998; Shepherd and Kahn, 1999; Michael et al., 2000). 
The mouse obviously adapted to loss of CHC22 and STX10, and 
the induction of diabetic symptoms in CHC22-transgenic mice 
suggests that the presence of one protein without the other is not 
favorable to mouse metabolism. The expanded GSC in some 
patients with type 2 diabetes has high levels of CHC22 associ-
ated with it (Vassilopoulos et al., 2009), raising the possibility that 
CHC22 modulation of GLUT4 traffic might influence human 
tendency toward type 2 diabetes. Thus, to study human diabetes 
in mouse models, the roles of both CHC22 and STX10 will have 
to be recapitulated. One exciting possibility is that the coexpres-
sion of these proteins might induce a human-like GSC in mice, 
leading to better mouse models of human glucose metabolism.
Materials and methods
Expression plasmids, antibodies, recombinant proteins, and siRNAs
Full-length human CHC22 was cloned from LHCNM2 skeletal muscle cells. 
mRNA was extracted using the RNeasy kit (QIAGEN) and transcribed into 
cDNA using SuperScript (Invitrogen). CHC22 was cloned into pT7blue 
cloning vector and subcloned into pEGFP-C1 and p3xFLAG-CMV-10 vec-
tors for expression in HeLa cells. siRNA-resistant FLAG-CHC22-KDP was 
generated by QuikChange mutagenesis (Agilent Technologies) using 
primers CAACAACTGGGAGGATTTGGTGAAATTTCTGCAGATG and 
CATCTGCAGAAATTTCACCAAATCCTCCCAGTTGTTG on CHC22 in 
p3xFLAG-CMV-10, resulting in three base changes without changing the 
amino acid sequence.
One monoclonal and two polyclonal antibodies that specifically rec-
ognize CHC22 and not CHC17 have been described previously (Liu et al., 
2001; Vassilopoulos et al., 2009). Anti-CHC17 antibodies (mouse mono-
clonals X22 and TD.1) and rabbit polyclonal antibody against clathrin light 
chains were generated in the Brodsky laboratory (Brodsky, 1985; Acton 
et al., 1993). Commercial sources of antibodies are as follows: TGN46 
(sheep polyclonal; AbD Serotec); EEA1, AP1, SNX1, GM130 (mouse 
monoclonal; BD); -tubulin, -actin, FLAG (mouse monoclonal; Sigma-
Aldrich); EEA1 (rabbit polyclonal; Cell Signaling Technology); GM130 
(rabbit polyclonal, Sigma-Aldrich); CI-MPR (mouse monoclonal, EMD); 
Cathepsin D (rabbit polyclonal; EMD); and SNX5 (goat polyclonal; Abcam). 
Mouse monoclonal anti-Rab9 and rabbit polyclonal anti-STX10 antibodies 
were gifts from Suzanne Pfeffer (Stanford University School of Medicine, 
Stanford, CA). Polyclonal anti–CI-MPR was a gift from Linton Traub (Univer-
sity of Pittsburgh, Pittsburgh, PA). The Rab11-GFP construct was a gift from 
Keith Mostov (University of California, San Francisco, San Francisco, CA). 
Secondary antibodies for immunofluorescence against mouse IgG, IgG1, 
IgG2a, rabbit IgG, sheep IgG, and goat IgG were from Invitrogen (Alexa 
Fluor 488, 555, 568, and 647 conjugates). Secondary antibodies coupled 
to HRP were from Invitrogen. Recombinant STxB coupled to Cy3 was pro-
duced as described previously (Mallard et al., 1998).
Targeting and nontargeting control siRNAs were synthesized by 
QIAGEN. DNA sequences targeted were AATTCTCCGAACGTGTCACGT for 
nontargeting control, AAGCAATGAGCTGTTTGAAGA for CHC17 (Huang 
et al., 2004), AAGAACAAGACCAAGAGCCAC for SNX1 (Bujny et al., 
2007), TATCCCACATGACGAGTGA for STX10 (Ganley et al., 2008), and 
TCGGGCAAATGTGCCAAGCAA and AACTGGGAGGATCTAGTTAAA 
for CHC22 (1:1 mixture of siRNAs were used; Vassilopoulos et al., 2009). 
In experiments shown in Fig. 4 E only the second siRNA against CHC22 
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enclosed in an area of 182.5 µm2 around the centerpoint (red circle in Fig. S4) 
were defined as perinuclear with peripheral signal representing the 
difference between total and perinuclear signal. The boundary of the peri-
nuclear area was set to include most of the Golgi staining for all cells ana-
lyzed. All calculations and graphs were performed and generated in 
Microsoft Excel and GraphPad Prism software. P-values were calculated 
using unpaired two-tailed Student’s t test. Figures were prepared in Adobe 
Photoshop and Illustrator software. Some data for this study were acquired 
at the Nikon Imaging Center at the Mission Bay campus of UCSF.
Online supplemental material
Fig. S1 shows minimal colocalization between endogenous CHC22 and 
CHC17, and a modest recruitment of CHC22 to the TGN but not to mitotic 
spindles in cells depleted of CHC17. Fig. S2 compares CHC22 localiza-
tion to various cellular markers and includes quantification for data in Fig. 3. 
Fig. S3 demonstrates that CHC22 distribution is not affected by Brefeldin 
A treatment. Fig. S4 illustrates the method used for measuring perinuclear 
vs. peripheral CI-MPR fluorescence. Fig. S5 shows control experiments for 
STxB uptake assays. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.200908057/DC1.
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